Loading...
Dr. Reddy's Laboratories Limited
RDY•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$14.41
$-0.14(-0.96%)
Dr. Reddy's Laboratories Limited (RDY) Financial Performance & Statements
Review Dr. Reddy's Laboratories Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
13.54%
↑ 13.54%
Operating Income Growth
18.52%
↑ 18.52%
Net Income Growth
23.56%
↑ 23.56%
Operating Cash Flow Growth
-22.83%
↓ 22.83%
Operating Margin
22.07%
↑ 22.07%
Gross Margin
58.50%
↑ 58.50%
Net Profit Margin
17.37%
↑ 17.37%
ROE
18.08%
↑ 18.08%
ROIC
19.81%
↑ 19.81%
Dr. Reddy's Laboratories Limited (RDY) Financial Statements
Explore quarterly and annual reports for Dr. Reddy's Laboratories Limited stock.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $85.06B | $83.59B | $80.16B | $76.73B |
| Cost of Revenue | $37.80B | $34.53B | $34.58B | $32.50B |
| Gross Profit | $47.26B | $49.05B | $45.58B | $44.23B |
| Gross Profit Ratio | $0.56 | $0.59 | $0.57 | $0.58 |
| R&D Expenses | $7.26B | $6.66B | $6.94B | $5.88B |
| SG&A Expenses | $24.05B | $24.12B | $21.15B | $20.89B |
| Operating Expenses | $29.62B | $30.33B | $30.22B | $26.68B |
| Total Costs & Expenses | $67.41B | $64.87B | $62.61B | $59.19B |
| Interest Income | $3.008B | $704.00M | $665.00M | $0.00 |
| Interest Expense | $656.00M | $818.00M | $757.00M | $598.00M |
| Depreciation & Amortization | $4.55B | $4.72B | $3.98B | $3.81B |
| EBITDA | $21.42B | $24.24B | $23.84B | $21.76B |
| EBITDA Ratio | $0.25 | $0.29 | $0.30 | $0.28 |
| Operating Income | $17.65B | $18.72B | $17.55B | $17.54B |
| Operating Income Ratio | $0.21 | $0.22 | $0.22 | $0.23 |
| Other Income/Expenses (Net) | $2.41B | $22.00M | $1.62B | $837.00M |
| Income Before Tax | $20.05B | $18.74B | $19.17B | $18.76B |
| Income Before Tax Ratio | $0.24 | $0.22 | $0.24 | $0.24 |
| Income Tax Expense | $4.18B | $4.70B | $5.75B | $4.90B |
| Net Income | $15.94B | $14.13B | $12.55B | $13.92B |
| Net Income Ratio | $0.19 | $0.17 | $0.16 | $0.18 |
| EPS | $19.13 | $16.96 | $15.04 | $83.58 |
| Diluted EPS | $19.11 | $16.94 | $15.04 | $83.46 |
| Weighted Avg Shares Outstanding | $832.73M | $832.73M | $832.73M | $832.73M |
| Weighted Avg Shares Outstanding (Diluted) | $833.93M | $833.93M | $833.93M | $833.93M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan